LINKPHCommodity Chemicals
Link Pharma Chem Ltd — Cash Flow Statement
₹22.66
-13.42%
Link Pharma Chem Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 2.69 Cr | -0.03 Cr | -2.60 Cr | -2.41 Cr | — |
| Repayment Of Debt | -0.74 Cr | -1.56 Cr | -1.37 Cr | -0.86 Cr | — |
| End Cash Position | 0.06 Cr | 0.06 Cr | 0.09 Cr | 0.27 Cr | — |
| Beginning Cash Position | 0.06 Cr | 0.09 Cr | 0.27 Cr | 4.22 Cr | — |
| Changes In Cash | 3000.00 | -0.03 Cr | -0.17 Cr | -3.95 Cr | — |
| Financing Cash Flow | -4.21 Cr | -0.41 Cr | 1.61 Cr | 2.27 Cr | — |
| Interest Paid Cff | -0.78 Cr | -0.87 Cr | -0.76 Cr | -0.45 Cr | — |
| Net Issuance Payments Of Debt | -3.44 Cr | 0.47 Cr | 2.37 Cr | 2.72 Cr | — |
| Net Short Term Debt Issuance | -2.69 Cr | 2.03 Cr | 3.20 Cr | 2.58 Cr | — |
| Net Long Term Debt Issuance | -0.74 Cr | -1.56 Cr | -0.84 Cr | 0.14 Cr | — |
| Long Term Debt Payments | -0.74 Cr | -1.56 Cr | -1.37 Cr | -0.86 Cr | — |
| Investing Cash Flow | 1.53 Cr | 0.41 Cr | -0.07 Cr | -4.97 Cr | — |
| Net Other Investing Changes | -0.26 Cr | -0.95 Cr | — | — | — |
| Interest Received Cfi | 0.05 Cr | 0.07 Cr | 0.07 Cr | 0.09 Cr | — |
| Dividends Received Cfi | 0.02 Cr | 0.02 Cr | 0.08 Cr | 82000.00 | — |
| Net Investment Purchase And Sale | 1.72 Cr | 1.15 Cr | 0.67 Cr | -4.32 Cr | — |
| Sale Of Investment | 2.08 Cr | 1.44 Cr | 4.09 Cr | 0.52 Cr | — |
| Purchase Of Investment | -0.36 Cr | -0.29 Cr | -3.42 Cr | -4.84 Cr | — |
| Net PPE Purchase And Sale | 0.00 | 0.12 Cr | -0.89 Cr | -0.74 Cr | — |
| Sale Of PPE | 0.00 | 0.12 Cr | 0.00 | 0.41 Cr | — |
| Operating Cash Flow | 2.69 Cr | -0.03 Cr | -1.71 Cr | -1.26 Cr | — |
| Taxes Refund Paid | 0.03 Cr | -0.37 Cr | -0.41 Cr | -0.67 Cr | — |
| Change In Working Capital | 2.53 Cr | 0.89 Cr | -4.43 Cr | -4.16 Cr | — |
| Change In Other Current Assets | -0.06 Cr | 1.38 Cr | 1.09 Cr | -0.34 Cr | — |
| Change In Payable | 2.00 Cr | -4.95 Cr | 0.65 Cr | -1.71 Cr | — |
| Change In Inventory | 0.47 Cr | 6.04 Cr | -7.49 Cr | -2.26 Cr | — |
| Change In Receivables | 0.11 Cr | -1.58 Cr | 1.32 Cr | 0.15 Cr | — |
| Other Non Cash Items | 0.73 Cr | 0.82 Cr | 0.73 Cr | 0.34 Cr | — |
| Provisionand Write Offof Assets | 0.02 Cr | 0.04 Cr | 0.02 Cr | 0.03 Cr | — |
| Depreciation And Amortization | 0.94 Cr | 1.03 Cr | 0.92 Cr | 0.93 Cr | — |
| Depreciation | 0.94 Cr | 1.03 Cr | 0.92 Cr | 0.93 Cr | — |
| Pension And Employee Benefit Expense | -0.03 Cr | 0.04 Cr | — | — | — |
| Gain Loss On Investment Securities | -0.14 Cr | -0.51 Cr | 0.18 Cr | -0.23 Cr | — |
| Gain Loss On Sale Of PPE | 0.00 | -0.08 Cr | 0.00 | -0.12 Cr | — |
| Net Income From Continuing Operations | -1.40 Cr | -1.92 Cr | 0.89 Cr | 2.62 Cr | — |
| Issuance Of Debt | — | 0.00 | 0.53 Cr | 1.00 Cr | 1.50 Cr |
| Capital Expenditure | — | -0.95 Cr | -0.89 Cr | -1.16 Cr | -1.81 Cr |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | — | — | — |
| Long Term Debt Issuance | — | 0.00 | 0.53 Cr | 1.00 Cr | 1.50 Cr |
| Purchase Of PPE | — | -0.95 Cr | -0.89 Cr | -1.16 Cr | -1.81 Cr |
| Net Other Financing Charges | — | — | — | -0.04 Cr | -0.02 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Link Pharma Chem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.